Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the expression of PCSK5 mRNA | affects expression | 18281256
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PCSK5 mRNA | affects expression | 21346803
|
D006710 |
Homocysteine |
Homocysteine results in decreased expression of PCSK5 mRNA | decreases expression | 17326132
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of PCSK5 mRNA | increases expression | 15761015
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PCSK5 mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PCSK5 mRNA | increases expression | 20106945
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of PCSK5 gene | increases mutagenesis | 18519639
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of PCSK5 mRNA | decreases expression | 18035473
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PCSK5 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PCSK5 mRNA | increases expression | 18301758
|
D012643 |
Selenium |
Selenium results in decreased expression of PCSK5 mRNA | decreases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PCSK5 mRNA | decreases expression | 17101203
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PCSK5 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 11752688 14514962 15322242 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.27 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.31 | 11798837 19825857 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.79 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.56 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.56 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001006 |
Anus, Imperforate |
marker/mechanism |
|
| 18519639 |
MESH:D001321 |
Autistic Disorder |
|
Homocysteine |
3.03 | 16297937 20468076 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
16.12 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
16.12 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
16.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
marker/mechanism |
|
| 18519639 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.01 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.42 | 16357521 16436596 15144691 16651633 18412241 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.69 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.48 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.95 | 15700767 10355542 15673190 16124888 15721981 16097048 16227642 18705752 3786805 16050911 16011737 16192424 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.70 | 15553829 14691202 11135700 16217749 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.70 | 18788625 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.09 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.25 | 12490120 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18670907 18850075 16120746 |
MESH:C535348 |
Caudal regression syndrome |
marker/mechanism |
|
| 18519639 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.24 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
7.24 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.20 | 17160924 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.10 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.10 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 16354765 15668235 12621046 8697196 15340226 |
MESH:D003092 |
Colitis |
|
Selenium |
3.95 | 17936198 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D003324 |
Coronary Artery Disease |
|
Homocysteine |
3.80 | 16379339 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.35 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.51 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 20055451 15322242 10048152 |
MESH:C536221 |
Currarino triad |
marker/mechanism |
|
| 18519639 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.19 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.24 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.29 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
9.29 | 6884620 19336974 17522070 7440962 15968718 11566570 10092053 15998439 10915739 3786805 4309450 16227642 21278145 7120509 15027814 19085960 9327722 3732212 2869522 16177239 7179309 6623471 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
9.29 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.29 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.20 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.00 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.00 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.34 | 12903497 |
MESH:D017889 |
Exfoliation Syndrome |
|
Homocysteine |
5.89 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
19.96 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
19.96 | 12795759 19224547 61145 16045604 12631006 17595544 15959796 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.96 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.96 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
15.77 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.77 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.77 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.42 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.41 | 8708960 |
MESH:D005901 |
Glaucoma |
|
Homocysteine |
5.44 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
3.92 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.54 | 16651633 18412241 16357521 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Homocysteine |
7.17 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
7.17 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.22 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.22 | 17162251 |
MESH:D006343 |
Heart Septal Defects |
marker/mechanism |
|
| 18519639 |
MESH:D006345 |
Heart Septal Defects, Ventricular |
marker/mechanism |
|
| 18519639 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.62 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.76 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
15.62 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.62 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.62 | 16120746 15340226 12621046 |
MESH:D006554 |
Hernia, Umbilical |
marker/mechanism |
|
| 18519639 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 16959395 8697196 18606429 15340226 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.73 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Homocysteine |
4.83 | 17292331 18234410 17369066 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.10 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.10 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.26 | 15338365 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.22 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.22 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.41 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.72 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
marker/mechanism |
|
| 18519639 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.66 | 15604871 |
MESH:D007674 |
Kidney Diseases |
marker/mechanism |
|
| 18519639 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.41 | 10903974 8314463 18776723 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.02 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.19 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.19 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
13.19 | 17379185 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.89 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.93 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.50 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.53 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.90 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.16 | 16968895 19850784 16467208 17050201 20471514 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.30 | 9834237 17869043 16823087 15622746 17217047 15748426 16112521 11161223 17107899 15336539 11468182 17649720 19035177 19225113 19642359 16330433 19075265 16331271 15213294 16966277 12712474 12679006 16891316 12018890 17712046 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.51 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.88 | 16221502 16943688 17334410 11903743 16239168 17157831 11408273 17174718 21278145 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.46 | 17565644 12666154 20821823 15370692 16097048 17721639 12609069 17761835 18472094 18210741 15893842 16015684 15650968 17823541 14748882 12898905 15959796 14512876 18263696 15925388 16033810 18006644 14724832 17698563 14716833 14716496 16136751 12445418 18156304 18279442 12586293 17557913 18395095 16248980 17976157 16638106 18277467 18339082 17766677 15818738 15052691 15730626 17525996 12632514 12741479 17708605 18187930 14620537 18166357 15338365 18418968 17714472 18481824 18205269 17631135 16027843 16192424 15123356 18472332 18054572 12632512 18395914 17481882 18251166 15931870 15673190 17869086 12389079 15876570 12546737 12667390 10355542 12445421 18412020 17640975 17922224 12649538 18376398 18317297 18429990 17944888 17805973 18420326 15362042 16011737 15996030 17900296 13678700 12958196 15057751 18705752 16116963 11481614 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.46 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.46 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.11 | 16964402 17285989 15720792 15830285 16246199 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.34 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.82 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
11.08 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
11.08 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.08 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.08 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
10.30 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.30 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.30 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.46 | 15213294 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
marker/mechanism |
|
| 18519639 |
MESH:D008171 |
Lung Diseases |
marker/mechanism |
|
| 18519639 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.58 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
3.58 | 16019985 17703301 16271038 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.58 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.04 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.22 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
6.66 | 10838139 10767621 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.66 | 15318939 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.20 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Homocysteine |
5.71 | 16602021 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.84 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.01 | 16801185 |
MESH:D009056 |
Mouth Abnormalities |
marker/mechanism |
|
| 18519639 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.20 | 14977855 11468182 19417148 19549372 15949261 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.89 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.22 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Homocysteine |
6.17 | 17412321 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.17 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.05 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.12 | 16624393 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.01 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.58 | 16707424 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.66 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.41 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.20 | 10525206 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.61 | 17160924 16003739 16651423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.56 | 16049721 12819281 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.20 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.44 | 19769630 16624393 12452020 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.57 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.31 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Homocysteine |
3.62 | 16275827 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.11 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.35 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.25 | 19131511 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.27 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.45 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.12 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Homocysteine |
3.12 | 16641680 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.62 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.10 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.35 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.19 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.15 | 15213294 |
MESH:D014138 |
Tracheoesophageal Fistula |
marker/mechanism |
|
| 18519639 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.25 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.25 | 20435036 12973940 12845720 11780464 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.51 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.20 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:C536534 |
VATER association |
marker/mechanism |
|
| 18519639 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.66 | 17120751 |